A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration

Intensive Care Medicine

Volumn 29, Issue 7, 2003, Pages 1186-1189

  Dorval, Marc ^a   Madore, François ^b   Courteau, Sylvie ^a   Leblanc, Martine ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Activated coagulation time; Anticoagulation; Citrate; Continuous venovenous hemodiafiltration; Ionized calcium

Indexed keywords

CALCIUM CHLORIDE; CALCIUM ION; CITRIC ACID; HEPARIN; ISOTONIC SOLUTION; MAGNESIUM SULFATE;

ACID BASE BALANCE; ADULT; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS HEMODIAFILTRATION; ELECTROLYTE BALANCE; FEMALE; FLUID THERAPY; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; MALE; SAFETY; THROMBOSIS;

ANTICOAGULANTS; CITRATES; HEMOFILTRATION; HUMANS;

EID: 0042667173     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-1801-4     Document Type: Article

References (6)

1. Metha R, McDonald B, Aguilar M, Ward D (1990) Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976-981
2. Kutsogiannis D, Mayers I, Chin W, Gibney R (2000) Regional Citrate Anticoagulation in Continuous Venovenous hemodiafiltration. Am J Kidney Dis 35:802-811
3. Palsson R, Niles J (1999) Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney int 55:1991-1997
4. Tolwani A, Campbell R, Schenk M, Allon M, Warnock D (2001) Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 60:370-374
5. Hocken A, Hurst P (1987) Citrate regional anticoagulation in hemodialysis. Nephron 46:7-10
6. Janssen M, Huijgens P, Bouman A, Oe P, Van der Meulen J (1994) Citrate anticoagulation and divalent cations in hemodialysis. Blood Purif 12:308-316